ADMA BIOLOGICS INC - COMMON STOCK

ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

28 أبريل 2025 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Statement on Tariffs

07 أبريل 2025 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

03 مارس 2025 16:05:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

28 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

25 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update

13 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025

07 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

20 ديسمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update

07 نوفمبر 2024 16:05:01 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024

29 أكتوبر 2024 16:10:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Set to Join S&P SmallCap 600 Index

17 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference

10 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces Partial Paydown of Revolving Credit Facility

14 أغسطس 2024 08:59:22 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update

08 أغسطس 2024 16:05:01 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024

01 أغسطس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update

09 مايو 2024 16:05:01 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024

02 مايو 2024 07:00:01 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®

11 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

05 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces CFO Transition

28 فبراير 2024 16:10:00 بحسب Nasdaq GlobeNewswire